Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Paclitaxel, Ifosfamide, and Carboplatin with Stem Cell Support for Resistant Germ Cell Tumors
NCT00423852Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Aug 2006
- Primary completion
- Feb 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, carboplatin, ifosfamide in germ cell tumor (GCT), sponsored by Memorial Sloan Kettering Cancer Center. Started Aug 2006; status: completed.
02
Drugs
paclitaxelcarboplatinifosfamide
03
Conditions
germ cell tumor (GCT)
Beyond the preview
Go deeper on NCT00423852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00423852.